Decision Analytic Modelling in the Economic Evaluation of Health Technologies
https://doi.org/10.2165/00019053-200017050-00003
Discover Books. Explore Knowledge.
Search and discover peer-reviewed scholarly literature, open-access articles, and research citations across DOAJ, PubMed Central, and OpenAlex.
https://doi.org/10.2165/00019053-200017050-00003
Abstract This chapter explores how health technology assessment (HTA) has evolved and the role of patient involvement in it. HTA seeks to inform decision-makers about the value of a health technology through a systematic process that assess...
https://doi.org/10.1007/978-3-032-11284-2_1
This open access volume focuses on the development of a P5 eHealth, a methodological resource for developing the health technologies of the future, based on patients’ personal characteristics and needs as the fundamental guidelines for desi...
https://doi.org/10.1007/978-3-030-27994-3
https://doi.org/10.3310/hta2160
BACKGROUND: Positron emission tomography (PET) is an expensive diagnostic imaging technology. Despite the long history of PET development, the costs and effectiveness of its use in routine clinical practice remain unknown. Against this back...
https://doi.org/10.3310/hta3160
The evolution of...
https://doi.org/10.18053/jctres.03.2017s3.006
PMC: 6412600
https://doi.org/10.1007/978-3-319-15744-3
The rapid rise of mobile health technologies, such as smartphone apps and wearable sensors, presents psychiatry with new tools of potential value in caring for patients. Novel diagnostic and therapeutic applications of these technologies ha...
https://doi.org/10.1097/nmd.0000000000000596
https://doi.org/10.1007/978-3-642-30732-4_16
OBJECTIVES: Since 1988, four government-funded health technology assessment (HTA) agencies have been established in Canada. This paper is a descriptive review of reports issued by these organizations during the period from 1988 to 1998. MET...
https://doi.org/10.1017/s0266462300102168
Perrin Beatty, Canadian minister of health and welfare, 1989–1991, said that Canada needs “a more coordinated approach across the country to ensure that all Canadians are benefiting from the advances being made in health technology.” These ...
https://doi.org/10.1503/cmaj.140698
PMC: 4284188
https://doi.org/10.1016/0160-7995(78)90006-0
Previously, our group-the International Working Group for HTA Advancement-proposed a set of fifteen Key Principles that could be applied to health technology assessment (HTA) programs in different jurisdictions and across a range of organiz...
https://doi.org/10.1017/s0266462309990833
Abstract Objective: To describe the physical, structural and operational conditions, as well as the main challenges faced by Evidence Centers (NEvs) recognized by the Evidence-Informed Policy Network (EVIPNet) Brazil. Methods: This is a...
10.1590/s2237-96222026v35e20250457.en
The concentration of magnesium is determined based on the absorbance of the Mg-Xylydil Blue-I complex solution use spectrophotometer. Based on the Lambert-Beer rule, the calculation of sample concentration is based on the formula A = Ԑ. b. ...
10.33086/ijmlst.v3i1.1876
OBJECTIVE: The goal of this scoping review was to summarize the current literature identifying barriers and opportunities that facilitate adoption of e-health technology by physicians. DESIGN: Scoping review. SETTING: MEDLINE, EMBASE, and P...
https://doi.org/10.2147/jmdh.s103881
PMC: 4975159
BACKGROUND: The application of mobile computing and communication technology is rapidly expanding in the fields of health care and public health. This systematic review will summarise the evidence for the effectiveness of mobile technology ...
https://doi.org/10.1186/1756-0500-3-250
PMC: 2976743
Methodology for evaluation of impact of health technology assessments (HTAs) is outlined and its use illustrated by applying it to 21 HTAs produced by CETS. Impact on policies and technology diffusion was identified in documents, through in...
https://doi.org/10.1017/s0266462300010242
Increasingly, health technology assessment (HTA) is used to aid decisions on the reimbursement of pharmaceuticals or recommendations for their use. The pharmaceutical industry seeks to work in partnership with HTA agencies; however, this pr...
https://doi.org/10.1017/s0266462302000193
Despite recommendations that patients be involved in the design and testing of health technologies, few reports describe how to involve patients in systematic and meaningful ways to ensure that applications are customized to meet their need...
https://doi.org/10.1097/ncn.0b013e31819f7c7c
PMC: 2818536